Abstract：【Objective】 To explore the value of CXC chemokine ligand 10 (CXCL10),fibroblast growth factor 21 (FGF-21),and 25-hydroxyvitamin D [(25-OH)D] in predicting the risk of adverse cardiovascular events in patients with acute myocardial infarction after percutaneous coronary intervention (PCI). 【Methods】 A total of 86 patients with AMI treated with PCI from March 2019 to December 2020 were included in the study. After treatment,the patients were effectively followed up for 1 year. They were divided into adverse cardiovascular events group (n=32) and non conscientious vascular events group (n=54) based on whether they had adverse cardiovascular events during the follow-up period. The levels of CXCL10,FGF-21,and 25-(OH)D were compared between the two groups. The predictive value of CXCL10,FGF-21,and 25-(OH)D levels on the risk of adverse cardiovascular events in patients with AMI after PCI was analyzed using the receiver operational characteristic curve (ROC curve). Multivariate logistic regression was used to analyze whether CXCL10,FGF-21,and 25-(OH)D were risk factors for adverse cardiovascular events in patients with AMI after PCI. 【Results】 The levels of CXCL10 and FGF-21 in the observation group were higher than those in the control group (P<0.05),and the levels of 25-(OH)D were lower than those in the control group (P<0.05). ROC curve analysis showed that the area under the curve of CXCL10,FGF-21,and 25-(OH)D predicting adverse cardiovascular events in patients with AMI after PCI was 0.822,0.716,and 0.764,respectively (all P<0.05). Logistic regression analysis showed that CXCL10,FGF-21,and 25-(OH)D were independent influencing factors for adverse cardiovascular events in patients with AMI after PCI (P<0.05). 【Conclusion】 CXCL10,FGF-21,and 25-(OH)D have important clinical value in predicting the risk of adverse cardiovascular events in patients with AMI after PCI.
樊剑云, 亢武祥. CXCL10、FGF-21、25-(OH)D预测急性心肌梗死患者PCI术后不良心血管事件发生风险的价值[J]. 医学临床研究, 2023, 40(3): 428-431.
FAN Jian-yun, KANG Wu-xiang. Value of CXCL10,FGF-21,and 25-(OH)D in Predicting the Risk of Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction after PCI. JOURNAL OF CLINICAL RESEARCH, 2023, 40(3): 428-431.
[1] LUO E,WANG D,YAN G,et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J].Cardiovasc Diabetol,2019,18(1):150-155. [2] 徐伟干,岑锦明,符岳,等. 急性心肌梗死患者CYP2C19基因多态性分布及氯吡格雷治疗对PCI术后不良心血管事件和再狭窄的影响[J].临床急诊杂志,2020,21(4):304-307. [3] 朱秀华,叶慧芳,杨丽. 参附注射液对急性心肌梗死病人PCI术中心肌TIMI血流分级及术后近期主要不良心脏事件的影响[J].中西医结合心脑血管病杂志,2020,18(13):2107-2111. [4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. [5] SCHUSTER A,BACKHAUS S J,STIERMAIER T,et al. Impact of right atrial physiology on heart failure and adverse events after myocardial infarction[J].J Clin Med,2020,9(1):210-215. [6] 魏来. 急性心肌梗死患者PCI术后主要不良心血管事件发生的影响因素[J].心血管康复医学杂志,2018,27(6):633-637. [7] SWIECKI P,SAWICKI R,KNAPP M,et al. Galectin-3 as the prognostic factor of adverse cardiovascular events in long-term follow up in patients after myocardial infarction-a pilot study[J].J Clin Med,2020,9(6):1640-1645. [8] 乔海霞,王鹏飞,郭靖涛,等. 血清Adropin,CXCL10水平对AMI患者PCI术后发生主要不良心血管事件的预测价值[J].山东医药,2021,61(4):32-35. [9] 刘雅婷,谷新顺,张芳,等. 前壁急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入术后主要不良心血管事件发生的影响因素[J].中华实用诊断与治疗杂志,2020,34(5):505-508. [10] HUANG D,GAO W,WU R,et al. D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction[J].Int J Cardiol,2020,15(5):21-24. [11] 陈雪斌. 急性心肌梗死患者经皮冠状动脉介入术后血清成纤维细胞生长因子21和髓过氧化物酶水平与预后的关系[J].中国动脉硬化杂志,2020,28(6):513-517. [12] THOMSEN A F,JACOBSEN P K,KOBER L,et al. Risk of arrhythmias after myocardial infarction in patients with left ventricular systolic dysfunction according to mode of revascularization:a cardiac arrhythmias and risk stratification after myocardial infarction (CARISMA) substudy[J].Europace,2021,23(4):616-623. [13] 陈洁,杨天贵,付鹏. 血清总25-(OH)D对急性心肌梗死患者近期预后的影响[J].中国动脉硬化杂志,2019,27(9):764-768.
2023, Vol. 40 
